Gefitinib Zentiva

Gefitinib Zentiva is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Zentiva is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC where other treatments may not be effective.

Common effects of Gefitinib Zentiva may include skin rash, diarrhea, and fatigue. Some users may also experience nausea or loss of appetite. These effects can vary in intensity and duration, and it's important to monitor any changes in health while taking this medication.

Gefitinib Zentiva should be handled with care, as it is intended for specific medical conditions. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this treatment.

Gefitinib Zentiva may interact with other medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain foods or supplements may also impact the effectiveness of this medication.